Cantor's Dentice sees personalized medicine spurring M&A - The Deal Pipeline (SAMPLE CONTENT: NEED AN ID?)
Subscriber Content Preview | Request a free trialSearch  
  Go

Video

Share  |  Reprint

Cantor's Dentice sees personalized medicine spurring M&A

Published July 17, 2012 at 8:28 AM


Robert Dentice, managing director and co-head of Cantor Fitzgerald & Co.'s healthcare investment banking unit predicts that healthcare content companies with diagnostic tests that aid in personalized medicine will become hot M&A targets for drugmakers and other life sciences companies. - George White

To see more from Dentice, watch "Cantor Fitzgerald's co-head of healthcare on WellPoint-Amerigroup."



Share:

Free preview

This is only a preview of The Deal's sophisticated coverage. Explore the real-time intelligence as researched and reported on by our team of financial journalists with a license to The Deal Pipeline. Click here for more information.

Meet the journalists



Movers & Shakers

Launch Movers and shakers slideshow

NBGI Private Equity appointed food and drinks industry veteran Tim Kelly as a senior adviser. For other updates launch today's Movers & shakers slideshow.

Video

Shop, then chop

Blackstone Real Estate and DDR divide 46 shopping centers in a $1.46 billion deal. More video

Sectors